Brian Berman1, Adriana Villa. 1. Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, FL 33136, USA. bberman@med.miami.edu
Abstract
BACKGROUND: Keloid treatment represents a therapeutic challenge. New adjuvant therapy is needed to reduce the high recurrence rate (50%) of excised keloids. OBJECTIVE: To describe the method for using imiquimod 5% cream in the prevention of keloid recurrence after surgery. METHODS: This is a review of the scientific rationale and clinical experience of using imiquimod 5% cream for keloid management. CONCLUSION: Topical application of imiquimod 5% cream after surgery reduces keloid recurrences.
BACKGROUND: Keloid treatment represents a therapeutic challenge. New adjuvant therapy is needed to reduce the high recurrence rate (50%) of excised keloids. OBJECTIVE: To describe the method for using imiquimod 5% cream in the prevention of keloid recurrence after surgery. METHODS: This is a review of the scientific rationale and clinical experience of using imiquimod 5% cream for keloid management. CONCLUSION: Topical application of imiquimod 5% cream after surgery reduces keloid recurrences.
Authors: Michael Sand; Daniel Sand; Pejman Boorboor; Benno Mann; Peter Altmeyer; Klaus Hoffmann; Falk G Bechara Journal: Head Face Med Date: 2007-03-12 Impact factor: 2.151